FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20565811000001105: Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1461521000001119 Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1461541000001112 Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Is a Product containing precisely hydroxychloroquine sulfate 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has active ingredient Hydroxychloroquine sulfate false Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has specific active ingredient Hydroxychloroquine sulfate true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) 60 tablet 6 x 10 tablets Has AMP True Hydroxychloroquine 200mg tablets (Blackrock Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start